Summary
To evaluate metabolic control and safety parameters (hypoglycaemia frequency and nasal mucosa physiology), 31 insulin-dependent diabetic patients were treated with intranasal insulin at mealtimes for 1 month and with subcutaneous fast-acting insulin at meals for another month in an open, crossover randomized trial. During both treatment periods the patients were treated with intermediate-acting insulin at bedtime. Six of the patients were withdrawn from the study during intranasal insulin therapy due to metabolic dysregulation. Serum insulin concentrations increased more rapidly and decreased more quickly during intranasal as compared with subcutaneous insulin administration. Metabolic control deteriorated, as assessed by haemoglobin A1c concentrations, slightly but significantly after intranasal as compared with subcutaneous insulin therapy. The bioavailability of intranasally applied insulin was low, since intranasal insulin doses were approximately 20 times higher than subcutaneous doses. The frequency of hypoglycaemia was similar during intranasal and subcutaneous insulin therapy, and nasal mucosa physiology was unaffected after intranasal insulin. We conclude that due to low bioavailability and to a high rate of therapeutic failure, intranasal insulin treatment is not a realistic alternative to subcutaneous insulin injections at the present time.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- IDDM:
-
Insulin-dependent diabetes mellitus
- NIDDM:
-
non-insulin-dependent diabetes mellitus
References
Wang PH (1993) Tight glucose control and diabetic complications. Lancet II: 129
Schade DS, Santiago JV, Skyler JS, Rizza RA (1983) Intensive insulin therapy. Medical Examination Publishing, Amsterdam
Berger M, Chepper HJ, Chantelau EA, Sonnenberg GE, Joergens V (1982) Absorption kinetics of subcutaneously injected insulin preparations. In: Skyler JS (ed) Insulin update: 1982. Exerpta Medica, Amsterdam, pp 97–110
Dreyer K, Vaag A, Bech K, Hansen P, SØrensen AR, Mygind N (1992) Intranasal administration of insulin with phospholipid as absorption inhancer: pharmacokinetics in normal subjects. Diab Med 9: 335–340
Pontiroli AE, Alberetto M, Secchi A, Dossi G, Bosi I, Pozza G (1982) Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects. BMJ 284: 303–336
Moses AC, Gordon GS, Carey MC, Flier JS (1983) Insulin administered intranasally as an insulin-bile salt aerosol: effectiveness and reproducibility in normal and diabetic subjects. Diabetes 32: 1040–1047
Salzman R, Manson JE, Griffing GTet al. (1985) Intranasal aerosolized insulin: mixed-meal studies and long term use in type 1 diabetes. N Engl J Med 312: 1078–1084
Frauman AG, Cooper ME, Parsons BJ, Jerums G, Louis WJ (1987) Long term use of intranasal insulin in insulin-dependent diabetic patients. Diabetes Care 10: 573–578
Frauman AG, Jerums G, Louis WJ (1987) Effects of intranasal insulin in non-obese type 2 diabetes. Diabetes Res Clin Pract 3: 197–202
Moriarty BG, Robson AM, Smallman LA, Drake-Lee AB (1991) Nasal mucociliary function: comparison of saccharin clearance with ciliary beat frequency. Rhinology 29: 173–179
Pedersen M, Sakakura Y, Winther B, Brofeldt S, Mygind N (1983) Nasal mucociliary transport, number of ciliated cells, and beating pattern in naturally acquired common cold. Eur J Respir Dis [Suppl] 128: 355–364
Hansen BJ, Osterhammel PA (1991) Morphometrical evaluations of nosecasts compared to acoustic rhinometry. The Journal of Japan Rhinologic Society 30: 124
Andersen L, Dinesen B, JØrgensen PN, Poulsen F, RØder ME (1993) Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39: 578–582
Armitage P (1971) Statistical methods in medical research. Blackwell, pp 189–217
El-Etr M, Slama G, Desplanque N (1987) Preprandial intranasal insulin as adjuvant therapy in type 2 diabetics. Lancet II: 1085–1086
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hilsted, J., Madsbad, S., Hvidberg, A. et al. Intranasal insulin therapy: the clinical realities. Diabetologia 38, 680–684 (1995). https://doi.org/10.1007/BF00401839
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00401839